Attovia Therapeutics
Pre-clinicalHarnessing ATTOBODY technology to bring treatments to patients where none exist or where current solutions fall short.
Founded
2022
Focus
Biologics
About
Harnessing ATTOBODY technology to bring treatments to patients where none exist or where current solutions fall short.
Funding History
2Total raised: $67M
Series A$60MFrazier Life SciencesOct 15, 2023
Seed$7MFrazier Life SciencesJun 15, 2022
Company Info
TypePrivate
Founded2022
LocationFremont, United States
StagePre-clinical
Contact
Sectors
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile